KPTI
NASDAQ · Biotechnology
Karyopharm Therapeutics Inc
$2.12
+0.17 (+8.72%)
Open$1.96
Previous Close$1.95
Day High$2.12
Day Low$1.91
52W High$10.99
52W Low$1.80
Volume—
Avg Volume4.34M
Market Cap45.10M
P/E Ratio—
EPS$-14.84
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+2,217.9% upside
Current
$2.12
$2.12
Target
$49.14
$49.14
$31.72
$49.14 avg
$61.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 284.16M | 291.15M | 24.30M |
| Net Income | -381,380,190 | -351,682,552 | -4,467,152 |
| Profit Margin | -134.2% | -127.5% | -18.4% |
| EBITDA | -297,214,760 | -289,297,153 | -5,147,496 |
| Free Cash Flow | — | — | -3,231,735 |
| Rev Growth | -2.4% | -2.4% | +18.6% |
| Debt/Equity | 3.78 | 3.78 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |